Configurable LIMS platform

LabFlow compared with LabWare.

Compared on structure rather than on ticks: what each product is, who it is sold to, what comes with it and what does not. For most readers of this page the answer is Beaker, and the reasons are in the second section rather than the last one.

Updated5 Aug 2026
EvidencePublic material only
Hands-onNone
LabFlow installs0

Read this part first, because it settles the question for most people.

This comparison is decided by a noun rather than by a feature. LabWare is a configurable LIMS platform organised around the sample; LabFlow is a clinical LIS organised around the patient. If your work has no patient in it, LabFlow is the wrong category and nothing below changes that. If it does, read the LIS against LIMS article before this page — it is the argument this comparison assumes.

Choose LabWare

Your work is organised around samples, batches and specifications rather than around people; you are in a regulated non-clinical setting; you need a platform you can configure to a process nobody else runs. Any one of these settles it.

Choose neither, yet

You do both — clinical work and regulated non-clinical work in the same organisation — and neither product covers the other half. That is a real position, it is common in hospital research settings, and the answer is usually two systems rather than one compromise.

Consider LabFlow

Clinical work, a patient at the centre of every result, multi-tenant from the start, and an explicit tolerance for a product nobody else is running yet.

The comparison

A configurable LIMS platform whose centre of gravity is the sample rather than the patient, used well beyond clinical laboratories. If you are weighing these two against each other, the first thing to settle is which of those two nouns your work is organised around.

The LIS against LIMS distinction is worth reading first, because this whole comparison is that article applied to two products. The short version: one is organised around a patient and the other around a sample, and that decides the data model, the permission model and the regulatory surface before anything else is discussed.

What LabWare is#

A configurable laboratory information management system, used well beyond clinical laboratories: pharmaceutical and biotechnology manufacturing, environmental testing, food and beverage, petrochemicals, contract research. Its centre of gravity is the sample and its provenance — aliquoting, batch genealogy, specifications, stability studies and certificates of analysis.

Configurability is the platform’s defining property and it is genuinely a different product philosophy. A LIMS platform expects to be shaped to a process, by an implementation team, over a project. That is expensive and it is why the product can serve industries with nothing in common.

What LabFlow is#

A clinical laboratory information system. A patient is a person rather than a visit; a reference interval resolves from their age, sex and condition at result time and is stored on the result; a result versions rather than being overwritten because a clinician may already have acted on it; and release is gated on quality control being in control for the run.

None of those five sentences means anything without a patient, which is the point of this comparison.

The noun decides it#

Ask what a result means if you remove the person from it.

In clinical work the answer is nothing. A haemoglobin of 9.1 is not a fact about a tube; it is a fact about a person, interpreted against their own previous values and their own reference interval, and acted on by a clinician who is responsible for them. Take the patient away and you have a measurement, not a result.

In LIMS work the answer is that it still means something. A batch either conforms to its specification or it does not, and the specification is a versioned document rather than a property of a person. There may be no human subject anywhere in the workflow.

Neither product can be talked into the other category. A LIMS retrofitted for clinical use has no place to record "who may see whose", which is the question a clinical access model exists to answer. A LIS pressed into batch work has to invent a patient for every sample, which is exactly as bad as it sounds.

Where LabWare is stronger#

Configurability, regulated non-clinical work, and breadth of deployment. All three are real and none is something LabFlow is trying to match.

Configurability means a process nobody else runs can be supported without the vendor writing code for you specifically. For a manufacturer with a validated process that is close to a requirement, because the software has to fit the process rather than the other way round.

Regulated non-clinical work means good manufacturing practice, electronic-records rules, stability programmes and the documentation those demand. LabFlow has no part of that surface and does not claim to.

Breadth of deployment means the product has met industries with genuinely different assumptions and survived all of them. That is a different kind of maturity from the clinical kind, and for the buyer it is worth the same.

Where LabFlow differs#

  • The patient spine comes for free: one person, one history, across visits and across laboratories.
  • Reference intervals resolve per person and the resolved values are stored on the result, so it stays interpretable after the laboratory revises its limits.
  • Quality control gates release, in the transition function rather than in the interface, and you can operate that gate on the home page.
  • Critical values have an escalation path with a recorded callback, which is a clinical obligation with no LIMS equivalent.
  • Consent is a first-class object: scoped by category, expiring by default, revocable, and the revocation is its own event.
  • It is configured rather than implemented. That is a limitation as much as a difference — see the next section.

What LabFlow does not have#

  • Any laboratory in production.
  • A configuration layer of the kind a LIMS platform means by the word. LabFlow has settings; it does not have a platform you can shape to an arbitrary process.
  • Batch genealogy, stability studies, specification versioning or certificates of analysis.
  • Good manufacturing practice or Part 11 documentation. The audit trail, versioning and capability model are built; the documentation package is planned work.
  • An implementation organisation. A LIMS implementation is a project with a team; LabFlow has neither.
  • Blood-bank functionality or a DICOM viewer, neither of which it claims.

Choose LabWare if#

  • Your samples are materials rather than people.
  • You are in a regulated non-clinical industry and the documentation surface is part of the purchase.
  • You need to configure the system to a process rather than adopt the process the system assumes.
  • Batch, specification and certificate are the nouns your work is built from.

Consider LabFlow if#

  • Every result belongs to a person and is interpreted against their own history.
  • You are multi-site or multi-client, and tenancy is a requirement rather than a deployment detail.
  • You want the clinical rules visible and operable rather than described in a demonstration.
  • You are explicitly willing to be the first installation.

Where both answers are wrong#

Some laboratories genuinely need both spines at once, and pretending otherwise would be the most useful-sounding and least honest thing this page could do.

  • Anatomical pathology and molecular laboratories are clinical and patient-centred, and run batch-shaped workflows full of blocks, slides, plates and runs.
  • Public-health and screening laboratories process volumes where the patient is a registry record, and the work looks like batch processing with a person attached.
  • Hospital research laboratories hold human material under consent constraints with no clinical result at the end.

In each of these, the question is which spine you would rather build yourself. LabFlow gives you the clinical one and leaves the batch work thin; a LIMS platform gives you the sample one and leaves the patient work absent. Neither answer is comfortable, and a vendor telling you their product covers both is telling you something worth checking.

The limits of this page.

Nobody here has used LabWare. There has been no trial environment, no demonstration, no conversation with an implementation team and no sight of a contract or a price. Every statement above about it is either publicly documented or follows structurally from what the product is, and where a statement is inference it is written as inference.

Specifically not verified: anything about licensing terms, pricing, implementation effort, current release capability, or how the product performs in a particular laboratory. Those are questions for LabWare, and a competitor’s comparison page is the worst available source for them.

If you represent LabWare, Inc. and something here is inaccurate, say so. It gets corrected in place with a dated note and the original wording quoted, exactly as a wrong article does.

Evidence behind this page

Public materialYes
Structural reasoningYes, and labelled
Hands-on useNone
Vendor briefingNone
Customer interviewsNone
Pricing dataNone, in either direction

A comparison page that does not publish this table is asking you to assume it has all six.

Five questions to put to both, and LabFlow's answers are already public.

These separate laboratory systems more reliably than any feature list, and each has an uncomfortable answer somewhere. Asking them of one vendor and not the other is how an evaluation ends up comparing a sales deck with a specification.

Show me a release refused because quality control was out of controlDemonstrated, not described. Then ask what an override looks like and whose name ends up on it. LabFlow refuses, quotes the rule, and records the override with a person and a reason.
Show me both versions of an amended resultIf the old value is gone, the record of what a clinician acted on is gone. LabFlow writes a new row at the next version pointing at the one it supersedes, and the superseded row stays released.
Which parts of the integration do you deliver and which do we run?LabFlow exports and imports HL7 v2 and FHIR as files, with no live feed. For a module inside a suite this question may not arise at all, which is precisely the advantage worth pricing.
Who answers at 03:00, and what is committed in writing?LabFlow's answer is nobody, with no service level agreement behind any response time. Ask the other vendor for the contractual version rather than the sales version.
Can we get every record out, audit trail included?Ask about the audit trail specifically. An export that omits it cannot answer a question about the past, which is the only question an export is ever really for.

LabFlow's answers to all five are on the features page and the FAQ, including the two where the honest answer costs a sale.

Trademarks

LabWare is a trademark of LabWare, Inc., used here only to identify the product being discussed. There is no affiliation, partnership, reseller arrangement or endorsement in either direction, and no logo, brand mark, screenshot or interface belonging to LabWare, Inc. appears anywhere on this site.

The other three comparisons

Dedicated clinical LIS

LabFlow compared with Sunquest

The closest of the four in what it is for, and the more useful page if you are independent. This is the comparison where the difference is about maturity rather than about category.

Read this one instead if Beaker is not genuinely available to you.

Inside an EHR suite

LabFlow compared with Cerner Millennium

The same structural position from a different vendor, now part of Oracle Health, with a long installed base and a different integration posture.

Also named on this site as a validated integration it never had.

Configurable LIMS platform

LabFlow compared with LabWare

Organised around the sample rather than the patient, and used well beyond clinical laboratories. The first thing to settle is which of those two nouns your work is built on.

The LIS against LIMS post is worth reading first.

If your work has no patient in it, this comparison was over before it started.

That is a category statement rather than a competitive one. A sample-centric platform and a patient-centric system are not two ways of doing the same job, and choosing between them on a feature comparison is how an organisation ends up with software that cannot express the question it needs to ask.

If your work does have a patient in it, the useful next step is the LIS against LIMS article, then a description of one bench. If it does not, LabWare is a serious platform and this page is not trying to talk you out of it.

No demo environment to sign into and no trial to start, because neither exists. The conversation is the honest first step and it can end in a no from either side.